elieve any sustained trend in surgical volume could represent an upside risk to 2014 guidance Adjusting for certain non- operating headwinds and ACA HCA's 2014 guidance assumes organic/base growth of -2% to -5% growth HCA's 2014 outlook assumes ACA benefit of 1-2% of EBITDA ($65M-$135A41. although